Evidence map›Paper›PMID 42347525›Full record

ArticleToxins2026

Enhancing Neuronal Networks with

Giovanna Arruda Caires, Isabela Souza Pereira, Carlos DeOcesano-Pereira, Daniel Carvalho Pimenta, Irina Kerkis, Juliana Mozer Sciani, Hugo Vigerelli

Abstract read
In one paragraph

Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Giovanna Arruda CairesPrograma de Pós-Graduação em Ciências-Toxinologia do Instituto Butantan, Sao Paulo 05503-900, Brazil.
Isabela Souza PereiraPrograma de Pós-Graduação em Ciências-Toxinologia do Instituto Butantan, Sao Paulo 05503-900, Brazil.
Carlos DeOcesano-PereiraCenter of Excellence in New Target Discovery, Butantan Institute, Sao Paulo 05503-900, Brazil.ORCID 0000-0002-8933-4474
Daniel Carvalho PimentaPrograma de Pós-Graduação em Ciências-Toxinologia do Instituto Butantan, Sao Paulo 05503-900, Brazil.ORCID 0000-0003-2406-0860
Irina KerkisPrograma de Pós-Graduação em Ciências-Toxinologia do Instituto Butantan, Sao Paulo 05503-900, Brazil.
Juliana Mozer ScianiLaboratory of Natural Products, São Francisco University, Bragança Paulista 12916-900, Brazil.ORCID 0000-0001-7213-206X
Hugo VigerelliPrograma de Pós-Graduação em Ciências-Toxinologia do Instituto Butantan, Sao Paulo 05503-900, Brazil.ORCID 0000-0002-8197-2260

Funding

National Council for Scientific and Technological Development 130247/2021-9
6 · The paper itself

Abstract

Neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, are hallmarked by the progressive degeneration of neuronal networks. Given the lack of disease-modifying cures, current therapies are limited to symptomatic relief. Here, we investigated the neurotrophic potential of the skin secretion (SS) from

Indexed as

BufonidaeNerve NetNeurodegenerative DiseasesNeuronsSkinAnimalsneurodegenerative diseasesRhinella schneideriskin secretion

Identifiers

PMID42347525
PMCPMC13308062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.